Response of Severe Psoriasis to Infliximab (2002)

Letters| April 27 2002 Response of Severe Psoriasis to Infliximab Subject Area: Dermatology , Immunology and Allergy Renz Mang; Renz Mang Department of Dermatology, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany Search for other works by this author on: This Site PubMed Google Scholar Helger Stege; Helger Stege Department of Dermatology, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany Search for other works by this author on: This Site PubMed Google Scholar Thomas Ruzicka; Thomas Ruzicka Department of Dermatology, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany Search for other works by this author on: This Site PubMed Google Scholar Jean Krutmann Jean Krutmann Department of Dermatology, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany Search for other works by this author on: This Site PubMed Google Scholar Dermatology (2002) 204 (2): 156–157. https://doi.org/10.1159/000051840 Article history Published Online: April 27 2002 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Renz Mang, Helger Stege, Thomas Ruzicka, Jean Krutmann; Response of Severe Psoriasis to Infliximab. Dermatology 1 July 2002; 204 (2): 156–157. https://doi.org/10.1159/000051840 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsDermatology Search Advanced Search Article PDF first page preview Close Modal Keywords: Psoriasis, Psoriatic arthritis, TNF-α, Infliximab This content is only available via PDF. 2002Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.